The Allegan generic drugmaker and store brand health products producer Perrigo Co. (NYSE: PRGO) Wednesday announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for Clindamycin Phosphate and Benzoyl Peroxide Gel 1.2%/2.5% and has notified Dow Pharmasciences, the owner of the New Drug Application, of its filing.
The Harvard Drug Group LLC of Livonia said its Major Pharmaceuticals division has purchased the Rugby over-the-counter pharmaceutical products and trademarks from Parsippany, N.J.-based Watson Pharmaceuticals Inc. (NYSE: WPI) for $117 million.
Perrigo Co. announced that it has signed a definitive agreement to acquire substantially all of the assets of Sergeant’s Pet Care Products Inc., a privately held, Omaha, Neb.-based manufacturer of over-the-counter companion animal health care products, for approximately $285 million in cash.
Perrigo Co. announced that it has received a final “Approval for Registration” letter from the Australian Therapeutic Goods Administration,permitting the company to sell generic temozolomide in Australia The letter also states that bioequivalence was met between the brand product, Temodar®, and the Company’s generic temozolomide, enabling listing on the Pharmaceutical Benefits Scheme or PBS.
Allegan-based Perrigo Co. Thursday announced that its board of directors declared a quarterly dividend of 7 cents a share.